
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Synaps Dx has the only minimally invasive highly accurate test, DISCERNTM, for Alzheimers Disease. Multidisciplinary teams at the NIH and the Rockefeller Neurosciences Institute, led by Dr. Alkon, over the last 30 years led to the development of the three biomarkers. The three biomarkers comprise an AD-Index assay, a Morphometric Imaging assay, and a PKC Epsilon assay. FDA has granted SDx Breakthrough Status. Our diagnostic biomarkers have been confirmed by autopsy validation (NIH Gold Standard)
Synaps dx operates in the Biotechnology industry.
Synaps dx's revenue is 11m - 100m
Synaps dx has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.